NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Klarsen (PA: ALACT)

 
ALACT Technical Analysis
5
As on 24th Dec 2024 ALACT STOCK Price closed @ 0.25 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 3.62 & Strong Sell for SHORT-TERM with Stoploss of 5.31 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

ALACTSTOCK Price

Open 0.25 Change Price %
High 0.25 1 Day 0.00 0.00
Low 0.24 1 Week 0.00 0.00
Close 0.25 1 Month -0.10 -28.57
Volume N/A 1 Year -5.21 -95.42
52 Week High 5.78 | 52 Week Low 0.24
 
PA France Most Active Stocks
FTI 5.91 -1.66%
VIEDS 0.72 4.35%
LAT 0.01 0.00%
ALEUP 0.05 25.00%
CGG 0.69 -2.82%
ALHYG 0.01 0.00%
VIV 2.53 1.20%
ACA 12.91 -0.92%
ALNRG 0.01 0.00%
FIPP 0.14 0.00%
 
PA France Top Gainers Stocks
ALEUP 0.05 25.00%
CNV 0.19 18.75%
ALPAU 1.43 16.26%
ALPAU 1.43 16.26%
GNRO 0.08 14.29%
PARRO 2.77 10.80%
ALENT 0.45 9.76%
2MX 7.46 8.43%
ATA 0.13 8.33%
ATA 0.13 8.33%
 
PA France Top Losers Stocks
MLSML 0.01 -50.00%
AKOM 4.06 -37.05%
AKOM 4.06 -37.05%
FPN 0.02 -33.33%
MLMAD 9.25 -15.91%
ALALO 0.23 -14.81%
ORP 7.90 -12.03%
MLMON 0.88 -12.00%
ALQWA 2.31 -11.15%
ALDNE 1.20 -8.40%
 
 
ALACT
Daily Charts
ALACT
Intraday Charts
Whats New @
Bazaartrend
ALACT
Free Analysis
 
ALACT Important Levels Intraday
RESISTANCE0.27
RESISTANCE0.26
RESISTANCE0.26
RESISTANCE0.26
SUPPORT0.24
SUPPORT0.24
SUPPORT0.24
SUPPORT0.23
 
ALACT Forecast December 2024
4th UP Forecast2.76
3rd UP Forecast1.95
2nd UP Forecast1.46
1st UP Forecast0.96
1st DOWN Forecast-0.46
2nd DOWN Forecast-0.96
3rd DOWN Forecast-1.45
4th DOWN Forecast-2.26
 
ALACT Weekly Forecast
4th UP Forecast0.79
3rd UP Forecast0.62
2nd UP Forecast0.51
1st UP Forecast0.40
1st DOWN Forecast0.10
2nd DOWN Forecast-0.01
3rd DOWN Forecast-0.12
4th DOWN Forecast-0.29
 
ALACT Forecast2024
4th UP Forecast11.39
3rd UP Forecast7.82
2nd UP Forecast5.61
1st UP Forecast3.4
1st DOWN Forecast-2.9
2nd DOWN Forecast-5.11
3rd DOWN Forecast-7.32
4th DOWN Forecast-10.89
 
 
ALACT Other Details
Segment EQ
Market Capital 5759019.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
ALACT Address
ALACT
 
ALACT Latest News
 
Your Comments and Response on Klarsen
 
ALACT Business Profile
Acticor Biotech SAS, a clinical stage biopharmaceutical company, develops drugs for the treatment of acute phase of thrombotic diseases. The company engages in developing glenzocimab, a humanized monoclonal antibody fragment that targets a specific platelet glycoprotein. It is involved in two clinical programs in Phase II/III registration for the treatment of ischemic stroke; and two other Phase II trials addressing major cardiovascular emergencies with clinical results expected in ischemic stroke and Covid-19 respiratory distress syndrome. The company was founded in 2013 and is headquartered in Paris, France. Address: Bâtiment Inserm U1148, Paris, France, 75877
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service